Nov 11, 2019 01:31PM bruinjamie21 wrote:
thank you. Here’s what was said after the biopsy 6 months ago and below that the original report that came back suspicious
Pathology has been provided for the two biopsied lesions in the left breast.
Pathology for the anterior lesion marked specimen
#1, marked with a rod-shaped clip reveals benign breast tissue. Pathology for
the posterior lesion marked specimen #2 marked with a barbell-shaped clip also
reveals benign breast tissue with pregnancy like changes.
No definitive diagnosis was demonstrated at either site. It is uncertain
whether there is concordance of pathologic and imaging findings. Biopsy may be
reflective particularly given the multiplicity of the initial findings and lack
of a dominant or high risk suspicious enhancing MRI abnormality. Short interval
MRI follow-up however, in 4-6 months is recommended to assess further stability
and this will help determine whether any additional pathologic sampling will be
Patient will follow-up with Dr.
FINAL ASSESSMENT: CATEGORY 3 PROBABLY BENIGN FINDING, RECOMMEND SHORT INTERVAL
2019 3:29 PMCLINICAL HISTORY: High risk patient, family history of breast cancer including a
mother with premenopausal cancer, mammographically dense breasts.
COMMENT: A bilateral breast MRI was obtained utilizing a breast coil. Axial and
sagittal T1 and T2-weighted imaging was obtained on a 1.5 Tesla GE magnet. Fat
saturation technique was utilized. For the enhanced component the patient
received intravenous Gadavist contrast material. Following contrast
administration, serial enhanced dynamic sagittal imaging was obtained through
both breasts at incremental time intervals. Subtraction images were generated.
The study was reviewed on a PACS workstation with the benefit of computer
There are no previous breast MRI studies for comparison. There are previous
mammograms with the most recent of February 2019 and another study of June 2015.
Breasts are partly fatty with patchy and confluent areas of parenchyma
throughout. There is mild background enhancement.
In the right breast there is no suspicious enhancing mass or suspicious regional
In the left breast at the upper outer aspect there is a nodule with peripheral
enhancement. It is well marginated. It is markedly T2 bright suggesting a
benign process. It measures close to 8 mm and appears to correspond with the
nodular density demonstrated on the recent mammograms. This was likely present
on the mammogram of 2015. Appearance as well as lack of change suggests a
In the anterior to central depth upper outer left breast there is a focal area
of enhancement, somewhat elongated or bandlike. This is best demonstrated at
sagittal location -88.17 and corresponding axial location 2.27. This is
indeterminate and biopsy is recommended. In the slightly more central depth
more medial left breast there are additional focal areas of enhancement. This
includes an abnormality central to posterior depth at the -70.17 sagittal
location and corresponding 14.27 axial location. Slightly more lateral at the
same axial plane there is additional enhancement at sagittal location -78.17 and
again axial location 14.27. There is also a tiny nodular enhancement at the
-80.17 sagittal location corresponding with axial location 4.67. Biopsy of one
of these additional areas is recommended suggested of the most prominent which
is at the posterior upper outer breast at the -78.17 location. If these are
benign then other abnormalities can be followed in short interval with MRI to
assess further stability.
There is no bulky or suspicious adenopathy bilaterally.
There is a markedly T2 bright nodule in the posterior depth left upper outer
breast thought to correspond with a mammographic nodule thought to date back to
2015 mammograms. Appearance and the stability suggests a benign process.
Continuing imaging follow-up is advised in short interval to assess further
There are multiple enhancing abnormalities which are small and scattered within
the left breast and biopsy is recommended of the two most prominent to exclude
malignancy. This includes that located at the sagittal location -86.17 and
another located at the axial location 14.27. If these are benign than the
others can be followed in short interval to assess further stability.